BIZZARI JEAN-PIERRE 4
4 · Aprea Therapeutics, Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
BIZZARI JEAN-PIERRE
Director
Transactions
- Award
Stock Options (Right to Buy)
2025-06-05+4,185→ 4,185 totalExercise: $1.81Exp: 2035-06-05→ Common Stock (4,185 underlying) - Award
Common Stock
2025-06-05+1,045→ 1,045 total
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.